All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date | 2006-000490-29 | Effect of 3-week AT-1 receptor blockade on insulin resistance in relation to endocrine activity of adipose tissue in patients with insulin resistance | bad-data | |
Not reported | 2006-000607-42 | Treatment of borderline changesin protocol biopsy 3 months after renal transplantation | 2015-04-13 | due-trials |
Not reported | 2007-007546-36 | Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal Insufficiency | 2013-11-18 | due-trials |
Completed, but no date | 2009-011106-42 | Aditive effects of omega-3 polyunsaturated fatty acids and pioglitazone in the treatment of type 2 diabetes mellitus | bad-data | |
Completed, but no date | 2010-024175-58 | Comparison of two treatment options for hypertension in heart transplant recipients Srovnání dvou způsobů léčby hypertenze u pacientů po transplantaci srdce | bad-data | |
Completed, but no date | 2012-001390-88 | Cardioprotective and metabolic effects of metformin in patients with heart failure and diabetes Kardioprotektivní a metabolické účinky metforminu u nemocných s diabetem a srdečním selháním | bad-data | |
Not reported | 2012-001638-33 | Cholesterol 7alpha-hydroxylase polymorphism as a predictor cholesterolemia responsiveness Polymorfismus cholesterol-7alfa-hydroxylasy jako prediktor odpovídavosti cholesterolémie | 2022-11-29 | due-trials |
Completed, report not yet due | 2013-004934-14 | EVEROLIMUS VERSUS MYCOPHENOLIC ACID IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE DIFFERENCES IN RETINAL NEOVASCULARIZATION IN PATIENTS WITH DIABETIC RETINOPATHY EVEROLIMUS VE... | 2023-12-31 | not-yet-due |
Not reported | 2014-005407-24 | Effect of early administration of eplerenone in patients after acute myocardial infarction Efekt časného podání eplerenonu u pacientů po akutním infarktu myokardu | 2016-05-02 | due-trials |
Not reported | 2016-001397-15 | A prospective, randomized study to compare the effect on tissue oxygenation and clinical outcome of autologous bone marrow-derived mononuclear cell therapy with standard treatment in patients with cri... | 2021-01-01 | due-trials |
Not reported | 2016-001398-34 | A prospective, randomized study to assess the effect of autologous bone marrow-derived mononuclear cell therapy and its combination with percutaneous transluminal angioplasty (PTA) in comparison with ... | 2021-01-01 | due-trials |
Completed, but no date | 2019-001997-27 | Rationalisation of ATB therapy in diabetic foot infection and its impact on the intestinal microbiota Racionalizace ATB terapie infekce u syndromu diabetické nohy a její vztah ke střevnímu mikrobio... | bad-data | |
Other | 2019-002240-24 | The evolution of advanced microangiopathic diabetic complications before and after simultaneous pancreas and kidney transplantation evaluated with progressive non-invasive methods VÝVOJ ORGÁNOVÝCH... | not-yet-due | |
Completed, report not yet due | 2019-003723-37 | rATG versus rATG combined with IVIG induction immunosuppression in HLA incompatible transplantation Randomizovaná, otevřená studie fáze III.b prokazující non-inferioritu indukční imunosuprese pomoc... | 2023-11-22 | not-yet-due |
Completed, report not yet due | 2020-003715-94 | INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi | 2023-11-27 | not-yet-due |
Not reported | 2022-000319-30 | Assessment of association between 3rd dose of mRNA vaccine and risk of SARS-CoV-2 infection in kidney transplant recipients, safety and immunogenicity assessment. Aspekty imunitní odpovědi a efekti... | 2023-01-20 | due-trials |